Related Experiment Video
Updated: Aug 22, 2025

05:53
Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
15.1K
High-Risk Oncogenic Human Cytomegalovirus
1Department Pathogens & Inflammation-EPILAB EA4266, University of Franche-Comté UBFC, 25000 Besançon, France.
Viruses
|November 11, 2022
Summary
Human cytomegalovirus (HCMV) can cause cancer by directly transforming cells. This review outlines the characteristics of these high-risk HCMV strains and their impact on cancer development.
Area of Science:
- Virology
- Oncology
- Immunology
Background:
- Human cytomegalovirus (HCMV) is a widespread herpesvirus, typically latent but capable of reactivation.
- HCMV genomic diversity may contribute to its role in promoting cancer development.
- Recent evidence highlights an oncogenic role for specific HCMV strains, termed high-risk (HR) HCMV.
Purpose of the Study:
- To define the criteria characterizing high-risk (HR) HCMV strains.
- To elucidate the molecular and phenotypic impact of HR-HCMV on infected cells.
- To understand the influence of HR-HCMV on the tumor microenvironment.
Main Methods:
- This review synthesizes existing literature on HCMV genetics, cellular transformation, and oncogenesis.
- Criteria for HR-HCMV identification are proposed based on molecular and phenotypic markers.
- The impact on cellular and microenvironmental factors relevant to tumor progression is analyzed.
Main Results:
- HR-HCMV strains possess distinct genetic and molecular features enabling direct cellular transformation.
- These strains induce significant phenotypic changes in infected cells, promoting cancerous characteristics.
- HR-HCMV influences the tumor microenvironment, potentially fostering tumor growth and spread.
Conclusions:
- Defining HR-HCMV criteria is crucial for understanding its oncogenic potential.
- HR-HCMV plays a direct role in cancer development through cellular transformation and microenvironment modulation.
- Further research into HR-HCMV is warranted to explore therapeutic and diagnostic strategies.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.3K
Induced Pluripotent Stem Cells
4.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.3K
Mechanisms of Retrovirus-induced Cancers
5.2K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K

